Early results from a new study suggest that a simple saliva test and powerful artificial intelligence algorithms could help doctors identify cancer patients at high risk for severe side effects ...

In this video, Jay Chhablani, MD, director of clinical research at the UPMC Vision Institute, professor of ophthalmology and ...

Cost-effectiveness watchdog NICE has recommended Lytenava as an option for wet AMD in adults who have signs of recent disease progression, no permanent structural damage to the central fovea ...